肝细胞肝癌的靶向及免疫治疗研究现状与进展(4)
[4]Ye SL，Yang J，Bie P，et al.Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma： subgroup analysis of the GIDEON study[J].BMC Cancer，2018，18(1)：247.[5]Jackson R，Psarelli EE，Berhane S，et al.Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer： A Meta-Analysis of Randomized Phase III Trials[J].J Clin Oncol ......
您现在查看是摘要页，全文长 2748 字符。